Trends in migraine incidence and age-period-cohort analysis in China from 1990 to 2019_Chinese Journal of Evidence-Based Medicine

Authors：

XU Ruoyu , WANG Jiachen , LIN Yuetong ,  FENG Shangang ,  ZHANG Jianhua

School of Public Health, Shandong Second Medical University, Weifang 261053, P. R. China;

Corresponding author：

FENG Shangang, Email: F4S1G8@163.com; ZHANG Jianhua, Email: zhangjh@wfmc.edu.cn

Keywords：

China; Migraine; Incidence; Age-period-cohort model

DOI：

10.7507/1672-2531.202306027

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate the incidence trend of migraine in Chinese from 1990 to 2019 in the global burden of disease database (GBD2019) and its effect on three factors: age, period and cohort. Methods Data came from GBD2019. Joinpoint software was used to analyze the changing trend of migraine incidence. We analyzed the age-period-cohort (APC) model of migraine in the Chinese population combined with Stata 17.0 software and estimated the age, period, and cohort effects of migraine incidence. Results From 1990 to 2019, the standardized incidence of migraine in the general population, men and women in China showed a fluctuating upward trend, and the average annual percentage change was 0.23%, 0.27% and 0.21%, respectively. The APC model showed that from 1990 to 2019, the risk of migraine in China decreased with the increase of age, showed a downward trend with the increase of the period, and increased with the increase of the birth cohort, indicating that the cohort effect played a dominant role in the risk of migraine in the current period, and the risk of women in the rear of the birth cohort began to be gradually higher than that of men. Conclusion The incidence of migraine in Chinese population is on the rise from 1990 to 2019, and the younger the age, the earlier the period, and the lower the birth cohort, the greater the risk of migraine, suggesting that the prevention and treatment of migraine in women aged 10 to 54 years should be strengthened to further reduce the incidence of migraine in China.

1.	Ashina M, Katsarava Z, Do TP, et al. Migraine: epidemiology and systems of care. Lancet, 2021, 397(10283): 1485-1495.
2.	Ashina M, Terwindt GM, Al-Karagholi MA, et al. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet, 2021, 397(10283): 1496-1504.
3.	GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 2017, 390(10100): 1084-1150.
4.	Stovner LJ, Hagen K, Linde M, et al. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain, 2022, 23(1): 34.
5.	Yu S, Liu R, Zhao G, et al. The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache, 2012, 52(4): 582-591.
6.	吴雪尔, 张豆豆, 潘杰. 偏头痛匿名标准化病人工具的开发及其在基层医疗机构质量评估中的应用. 现代预防医学, 2023, 50(13): 2402-2409.
7.	黎运凤, 樊旭, 陈汐, 等. 偏头痛的国内外研究进展. 实用中医内科杂志, 2022, 36(3): 76-79.
8.	The Lancet Neurology None. Migraine matters. Lancet Neurol, 2021, 20(11): 877.
9.	Jiang W, Liang GH, Li JA, et al. Migraine and the risk of dementia: a meta-analysis and systematic review. Aging Clin Exp Res, 2022, 34(6): 1237-1246.
10.	Steiner TJ, Stovner LJ, Dua T, et al. Time to act on headache disorders. J Headache Pain, 2011, 12(5): 501-503.
11.	宇传华, 崔芳芳. 全球疾病负担研究及其对我国的启示. 公共卫生与预防医学, 2014, 25(2): 1-5.
12.	GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1160-1203.
13.	GBD 2019 Universal Health Coverage Collaborators. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1250-1284.
14.	黄照, 马文军. 年龄-时期-队列模型. 华南预防医学, 2017, 43(4): 373-376.
15.	陈悦, 沈婉莹, 陈磊, 等. 基于年龄-时期-队列模型分析1990-2019年中国肝癌发病趋势. 中国预防医学杂志, 2021, 22(5): 329-335.
16.	GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol, 2018, 17(11): 954-976.
17.	陈磊, 徐杰茹, 王冕, 等. 1990-2019年中国肾癌死亡趋势及其年龄-时期-队列分析. 中华疾病控制杂志, 2021, 25(9): 1026-1033,1111.
18.	Murphy CC, Yang YC. Use of age-period-cohort analysis in cancer epidemiology research. Curr Epidemiol Rep, 2018, 5(4): 418-431.
19.	李元明, 郝娟, 伊斯拉木江·吐尔逊, 等. 卵圆孔未闭合并偏头痛患者NTRK3基因表达水平及其与临床指标相关性分析. 实用临床医药杂志, 2023, 27(17): 117-121.
20.	头面痛学组. 中国偏头痛诊断治疗指南. 中国疼痛医学杂志, 2011, 17(2): 65-86.
21.	冯智英, 李颖, 邹静, 等. 发病年龄与偏头痛临床特点的关系分析. 上海交通大学学报(医学版), 2011, 31(10): 1448-1451.
22.	Lafrenière RG, Cader MZ, Poulin JF, et al. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med, 2010, 16(10): 1157-1160.
23.	李媛媛, 朱立勋, 周璐瑶, 等. 妊娠期偏头痛研究进展. 浙江医学, 2023, 45(16): 1774-1776,1792.
24.	Wang H, He H, Miao M, et al. Maternal migraine and the risk of psychiatric disorders in offspring: a population-based cohort study. Epidemiol Psychiatr Sci, 2021, 30: e55.
25.	Schwedt TJ, Hentz JG, Sahai-Srivastava S, et al. Headache characteristics and burden from chronic migraine with medication overuse headache: cross-sectional observations from the medication overuse treatment strategy trial. Headache, 2021, 61(2): 351-362.
26.	Takeshima T, Wan Q, Zhang Y, et al. Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature. J Headache Pain, 2019, 20(1): 111.
27.	Li X, Zhou J, Tan G, et al. Diagnosis and treatment status of migraine: a clinic-based study in China. J Neurol Sci, 2012, 315(1-2): 89-92.
28.	Buse DC, Greisman JD, Baigi K, et al. Migraine progression: a systematic review. Headache, 2019, 59(3): 306-338.
29.	Wang KA, Wang JC, Lin CL, et al. Association between fibromyalgia syndrome and peptic ulcer disease development. PLoS One, 2017, 12(4): e0175370.
30.	Nuyen J, Schellevis FG, Satariano WA, et al. Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study. J Clin Epidemiol, 2006, 59(12): 1274-1284.
31.	朱琳, 张宝学, 王丙参. 中国人口质量的时空差异和收敛性分析. 统计与决策, 2023, (19): 87-91.
32.	陈岱云, 陈希. 中国社会发展促人口性别结构变动—基于新中国成立以来人口性别比资料的分析. 东岳论丛, 2023, 44(9): 164-177, 192.
33.	Kalogeropoulos A, Georgiopoulou V, Psaty BM, et al. Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol, 2010, 55(19): 2129-2137.
34.	Scharff L, Turk DC, Marcus DA. Triggers of headache episodes and coping responses of headache diagnostic groups. Headache, 1995, 35(7): 397-403.
35.	张颖博. 偏头痛患者的饮食诱发因素. 国际神经病学神经外科学杂志, 2015, 42(6): 544-548.
36.	GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2019, 393(10184): 1958-1972.
37.	Smitherman TA, Burch R, Sheikh H, et al. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache, 2013, 53(3): 427-436.
38.	Del Boca D, Oggero N, Profeta P, et al. Women's and men's work, housework and childcare, before and during COVID-19. Rev Econ Househ, 2020, 18(4): 1001-1017.
39.	Todd C, Lagman-Bartolome AM, Lay C. Women and migraine: the role of hormones. Curr Neurol Neurosci Rep, 2018, 18(7): 42.
40.	杨倩, 于生元, 梁景耀. 偏头痛与心境障碍关系的Meta分析. 中国疼痛医学杂志, 2013, 19(5): 276-281.
41.	Sauro KM, Becker WJ. The stress and migraine interaction. Headache, 2009, 49(9): 1378-1386.

1. Ashina M, Katsarava Z, Do TP, et al. Migraine: epidemiology and systems of care. Lancet, 2021, 397(10283): 1485-1495.
2. Ashina M, Terwindt GM, Al-Karagholi MA, et al. Migraine: disease characterisation, biomarkers, and precision medicine. Lancet, 2021, 397(10283): 1496-1504.
3. GBD 2016 Mortality Collaborators. Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet, 2017, 390(10100): 1084-1150.
4. Stovner LJ, Hagen K, Linde M, et al. The global prevalence of headache: an update, with analysis of the influences of methodological factors on prevalence estimates. J Headache Pain, 2022, 23(1): 34.
5. Yu S, Liu R, Zhao G, et al. The prevalence and burden of primary headaches in China: a population-based door-to-door survey. Headache, 2012, 52(4): 582-591.
6. 吴雪尔, 张豆豆, 潘杰. 偏头痛匿名标准化病人工具的开发及其在基层医疗机构质量评估中的应用. 现代预防医学, 2023, 50(13): 2402-2409.
7. 黎运凤, 樊旭, 陈汐, 等. 偏头痛的国内外研究进展. 实用中医内科杂志, 2022, 36(3): 76-79.
8. The Lancet Neurology None. Migraine matters. Lancet Neurol, 2021, 20(11): 877.
9. Jiang W, Liang GH, Li JA, et al. Migraine and the risk of dementia: a meta-analysis and systematic review. Aging Clin Exp Res, 2022, 34(6): 1237-1246.
10. Steiner TJ, Stovner LJ, Dua T, et al. Time to act on headache disorders. J Headache Pain, 2011, 12(5): 501-503.
11. 宇传华, 崔芳芳. 全球疾病负担研究及其对我国的启示. 公共卫生与预防医学, 2014, 25(2): 1-5.
12. GBD 2019 Demographics Collaborators. Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950-2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1160-1203.
13. GBD 2019 Universal Health Coverage Collaborators. Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet, 2020, 396(10258): 1250-1284.
14. 黄照, 马文军. 年龄-时期-队列模型. 华南预防医学, 2017, 43(4): 373-376.
15. 陈悦, 沈婉莹, 陈磊, 等. 基于年龄-时期-队列模型分析1990-2019年中国肝癌发病趋势. 中国预防医学杂志, 2021, 22(5): 329-335.
16. GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol, 2018, 17(11): 954-976.
17. 陈磊, 徐杰茹, 王冕, 等. 1990-2019年中国肾癌死亡趋势及其年龄-时期-队列分析. 中华疾病控制杂志, 2021, 25(9): 1026-1033,1111.
18. Murphy CC, Yang YC. Use of age-period-cohort analysis in cancer epidemiology research. Curr Epidemiol Rep, 2018, 5(4): 418-431.
19. 李元明, 郝娟, 伊斯拉木江·吐尔逊, 等. 卵圆孔未闭合并偏头痛患者NTRK3基因表达水平及其与临床指标相关性分析. 实用临床医药杂志, 2023, 27(17): 117-121.
20. 头面痛学组. 中国偏头痛诊断治疗指南. 中国疼痛医学杂志, 2011, 17(2): 65-86.
21. 冯智英, 李颖, 邹静, 等. 发病年龄与偏头痛临床特点的关系分析. 上海交通大学学报(医学版), 2011, 31(10): 1448-1451.
22. Lafrenière RG, Cader MZ, Poulin JF, et al. A dominant-negative mutation in the TRESK potassium channel is linked to familial migraine with aura. Nat Med, 2010, 16(10): 1157-1160.
23. 李媛媛, 朱立勋, 周璐瑶, 等. 妊娠期偏头痛研究进展. 浙江医学, 2023, 45(16): 1774-1776,1792.
24. Wang H, He H, Miao M, et al. Maternal migraine and the risk of psychiatric disorders in offspring: a population-based cohort study. Epidemiol Psychiatr Sci, 2021, 30: e55.
25. Schwedt TJ, Hentz JG, Sahai-Srivastava S, et al. Headache characteristics and burden from chronic migraine with medication overuse headache: cross-sectional observations from the medication overuse treatment strategy trial. Headache, 2021, 61(2): 351-362.
26. Takeshima T, Wan Q, Zhang Y, et al. Prevalence, burden, and clinical management of migraine in China, Japan, and South Korea: a comprehensive review of the literature. J Headache Pain, 2019, 20(1): 111.
27. Li X, Zhou J, Tan G, et al. Diagnosis and treatment status of migraine: a clinic-based study in China. J Neurol Sci, 2012, 315(1-2): 89-92.
28. Buse DC, Greisman JD, Baigi K, et al. Migraine progression: a systematic review. Headache, 2019, 59(3): 306-338.
29. Wang KA, Wang JC, Lin CL, et al. Association between fibromyalgia syndrome and peptic ulcer disease development. PLoS One, 2017, 12(4): e0175370.
30. Nuyen J, Schellevis FG, Satariano WA, et al. Comorbidity was associated with neurologic and psychiatric diseases: a general practice-based controlled study. J Clin Epidemiol, 2006, 59(12): 1274-1284.
31. 朱琳, 张宝学, 王丙参. 中国人口质量的时空差异和收敛性分析. 统计与决策, 2023, (19): 87-91.
32. 陈岱云, 陈希. 中国社会发展促人口性别结构变动—基于新中国成立以来人口性别比资料的分析. 东岳论丛, 2023, 44(9): 164-177, 192.
33. Kalogeropoulos A, Georgiopoulou V, Psaty BM, et al. Inflammatory markers and incident heart failure risk in older adults: the Health ABC (Health, Aging, and Body Composition) study. J Am Coll Cardiol, 2010, 55(19): 2129-2137.
34. Scharff L, Turk DC, Marcus DA. Triggers of headache episodes and coping responses of headache diagnostic groups. Headache, 1995, 35(7): 397-403.
35. 张颖博. 偏头痛患者的饮食诱发因素. 国际神经病学神经外科学杂志, 2015, 42(6): 544-548.
36. GBD 2017 Diet Collaborators. Health effects of dietary risks in 195 countries, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet, 2019, 393(10184): 1958-1972.
37. Smitherman TA, Burch R, Sheikh H, et al. The prevalence, impact, and treatment of migraine and severe headaches in the United States: a review of statistics from national surveillance studies. Headache, 2013, 53(3): 427-436.
38. Del Boca D, Oggero N, Profeta P, et al. Women's and men's work, housework and childcare, before and during COVID-19. Rev Econ Househ, 2020, 18(4): 1001-1017.
39. Todd C, Lagman-Bartolome AM, Lay C. Women and migraine: the role of hormones. Curr Neurol Neurosci Rep, 2018, 18(7): 42.
40. 杨倩, 于生元, 梁景耀. 偏头痛与心境障碍关系的Meta分析. 中国疼痛医学杂志, 2013, 19(5): 276-281.
41. Sauro KM, Becker WJ. The stress and migraine interaction. Headache, 2009, 49(9): 1378-1386.

Chinese Journal of Evidence-Based Medicine

Latest ArticlesTrends in migraine incidence and age-period-cohort analysis in China from 1990 to 2019

Abstract Full text Figures/Tables Video References Cited by

Format

Content